Carlos Hernandez-Cassis, MD
Endocrinology, Diabetes & Metabolism · Henderson, NVNPI 1952366197
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $790 and has fallen 64.3% since, to $282 in 2025. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in NV, where the typical reported total is $4,060.
Across 64 payments — averaging $43.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$448
- Corcept Therapeutics$340
- Chiesi USA, Inc.$206
- Insulet Corporation$169
- Lilly USA, LLC$161
- AbbVie$158
- plus $1K from 24 others
Across 30 payments — averaging $1546.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$27K
- Boehringer Ingelheim International GmbH$17K
- GSK$2K
What the payments were for
- Food & beverage$2,72197%
- Education$923%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 7 | $448 |
| Corcept Therapeutics | 4 | $340 |
| Chiesi USA, Inc. | 2 | $206 |
| Insulet Corporation | 4 | $169 |
| Lilly USA, LLC | 3 | $161 |
| AbbVie | 3 | $158 |
| Radius Health, Inc. | 2 | $151 |
| Bayer | 2 | $145 |
| Ascendis Pharma Endocrinology Inc | 3 | $143 |
| Sanofi-aventis U.S. LLC | 2 | $130 |
| Madrigal Pharmaceuticals | 1 | $125 |
| Dexcom, Inc. | 3 | $117 |
| Amgen(2 entities) | 4 | $71 |
| Averitas Pharma Inc. | 3 | $68 |
| Recordati_rare_diseases_inc. | 2 | $50 |
| Medtronic | 2 | $39 |
| Scilex Pharmaceuticals Inc. | 2 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Tersera Therapeutics LLC | 1 | $29 |
| Appliedvr Inc | 1 | $22 |
| Abbott | 1 | $21 |
| Ionis Pharmaceuticals, Inc. | 1 | $21 |
| Boston Scientific | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Saluda Medical Americas, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Biodelivery Sciences International, Inc. | 1 | $16 |
| Zyla Life Sciences, Inc. | 1 | $16 |
| GRT US Holding, Inc. | 2 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,813 in reported general payments places this provider in the 45th percentile of 75 endocrinology, diabetes & metabolism providers in Nevada.
See all endocrinology, diabetes & metabolism providers in Nevada →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metformin Hcl | 12 | $18 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Henderson
- Quang NguyenHenderson$378K
- William LitchfieldHenderson$288K
- Claudia VogelHenderson$12K
- Omer TararHenderson$5K
- Amira IbrahimHenderson$2K
- Sehrish WaheedHenderson$835
- Farrukh IqbalHenderson$729
- Nitesh KuhadiyaReno$595K
- Samer NakhleLas Vegas$466K
- Chakravarthy KannanLas Vegas$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.